U-Blot® Research Grade CevostamabCat. No. WA2596$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade CevostamabCat. No. WA2596
U-Blot® Research Grade CetuximabCat. No. WA2595
U-Blot® Research Grade CetrelimabCat. No. WA2594
U-Blot® Research Grade CertolizumabCat. No. WA2593
U-Blot® Research Grade CergutuzumabCat. No. WA2592
U-Blot® Research Grade CepeprubartCat. No. WA2591
U-Blot® Research Grade cenzestotugCat. No. WA2590
U-Blot® Research Grade cenvacibartCat. No. WA2589
U-Blot® Research Grade CendakimabCat. No. WA2588
U-Blot® Research Grade CemiplimabCat. No. WA2587
U-Blot® Research Grade CemavafuspCat. No. WA2586
U-Blot® Research Grade CedelizumabCat. No. WA2585